+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genotyping - Global Market Trajectory & Analytics

  • ID: 4805047
  • Report
  • April 2021
  • Region: Global
  • 154 Pages
  • Global Industry Analysts, Inc
Global Genotyping Market to Reach $46.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Genotyping estimated at US$13.9 Billion in the year 2020, is projected to reach a revised size of US$46.4 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Polymerase Chain Reaction (PCR), one of the segments analyzed in the report, is projected to record a 18.6% CAGR and reach US$16.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing segment is readjusted to a revised 19.6% CAGR for the next 7-year period.



The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 18.4% CAGR

The Genotyping market in the U.S. is estimated at US$4.2 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$8.2 Billion by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.7% and 15.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.1% CAGR.

Microarray Segment to Record 18.9% CAGR

In the global Microarray segment, USA, Canada, Japan, China and Europe will drive the 18.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.5 Billion in the year 2020 will reach a projected size of US$8.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.4 Billion by the year 2027.

Select Competitors (Total 46 Featured):
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Life Technologies Corporation
  • Qiagen NV
  • Roche Diagnostics
  • Sequenom, Inc.
Frequently Asked Questions about the Global Market for Genotyping

What is the estimated value of the Global Market for Genotyping?

The Global Market for Genotyping was estimated to be valued at $13.9 Billion in 2020.

What is the growth rate of the Global Market for Genotyping?

The growth rate of the Global Market for Genotyping is 18.8%, with an estimated value of $46.4 Billion by 2027.

What is the forecasted size of the Global Market for Genotyping?

The Global Market for Genotyping is estimated to be worth $46.4 Billion by 2027.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Genotyping - A Prelude
  • Increasing Incidence of Genetic Diseases Propels the Genotyping Assays Market
  • Which Genotyping Techniques Can be Adopted???
  • Impact of Covid-19 and a Looming Global Recession
  • SEQUENCING TECHNOLOGIES TAKE THE MAJOR MARKET SHARE
  • Expanding Applications of DNA Sequencing Offer Significant Opportunities for the Genotyping Market
  • Decline in DNA Sequencing Costs Boosts Market Expansion
  • The Race for $100 Genome Gets Closer
  • Rising Demand for Hybrid Capture-Based Next Generation Sequencing
  • Use of Genotyping in Drug Development Drives Market Opportunities
  • Growth in Adoption of Plant and Animal Sequencing in Agricultural Research
  • A Peek into the Genome Sequencing Projects
  • GENOTYPING REAGENTS DOMINATE THE MARKET BY PRODUCT TYPE
  • Table 1: World Current & Future Analysis for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for MALDI-TOF by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for MALDI-TOF by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Capillary Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Genotyping Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Genotyping Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 21: World Current & Future Analysis for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 22: World 7-Year Perspective for Bioinformatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • Active Players in United States
  • Table 23: USA Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 25: USA Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Canada
  • Table 27: Canada Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 29: Canada Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Japan
  • Table 31: Japan Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Japan 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 33: Japan Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: Japan 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in China
  • Table 35: China Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: China 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 37: China Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: China 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Table 39: Europe Current & Future Analysis for Genotyping by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 40: Europe 7-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 41: Europe Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: Europe 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 43: Europe Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Europe 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in France
  • Table 45: France Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: France 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 47: France Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: France 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Germany
  • Table 49: Germany Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Germany 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 51: Germany Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: Germany 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Italy
  • Table 53: Italy Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: Italy 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 55: Italy Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Italy 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in United Kingdom
  • Table 57: UK Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: UK 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 59: UK Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: UK 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Rest of Europe
  • Table 61: Rest of Europe Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Rest of Europe 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 63: Rest of Europe Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Rest of Europe 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Asia-Pacific
  • Table 65: Asia-Pacific Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Asia-Pacific 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 67: Asia-Pacific Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Asia-Pacific 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027
  • Active Players in Rest of World
  • Table 69: Rest of World Current & Future Analysis for Genotyping by Technology - Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 70: Rest of World 7-Year Perspective for Genotyping by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction (PCR), Sequencing, Microarray, MALDI-TOF, Capillary Electrophoresis and Other Technologies for the Years 2020 & 2027
  • Table 71: Rest of World Current & Future Analysis for Genotyping by Product - Reagents & Kits, Genotyping Services, Instruments and Bioinformatics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 72: Rest of World 7-Year Perspective for Genotyping by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Genotyping Services, Instruments and Bioinformatics for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown